Originally designed to help manage type 2 diabetes, GLP-1 receptor agonists have gained widespread attention for another reason: their ability to support significant, sustained weight loss
When somebody loses weight whether thats with diet changes, an increase in physical activity, medication or bariatric surgery we know theres a reduction in fat mass, as well as a reduction in muscle mass
If I could only add one peptide to a Retatrutide protocol, BPC-157 would be my choice
If youre on the lighter side, you might not need as much to get the benefits
Publishers note All claims expressed in this article can solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers